Oxford, United Kingdom

Timothy E Peto

This inventor holds 1 USPTO granted patent. Top assignee: British Technology Group Limited. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy E. Peto

Introduction

Timothy E. Peto is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating parasitic infections. His work has implications for addressing critical health issues, such as malaria.

Latest Patents

Timothy E. Peto holds a patent for "3-hydroxy-pyridin-4-ones useful for treating parasitic infections." This patent describes compounds of the formula (I), where R1 is a C3 or C4 hydroxyalkyl group, R2 is methyl or ethyl, and R3 and R4 can be hydrogen, methyl, or ethyl. The compounds are valuable for treating conditions caused by iron-dependent parasites, particularly malaria, and may exist in the form of physiologically acceptable salts or pro-drugs.

Career Highlights

Peto is associated with the British Technology Group Limited, where he has been instrumental in advancing research and development in pharmaceutical applications. His innovative approach has led to the creation of effective treatments that can significantly impact public health.

Collaborations

Timothy E. Peto has collaborated with esteemed colleagues, including Robert Charles Hider and Surinder Singh. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Timothy E. Peto's contributions to the field of medicinal chemistry and his innovative patents highlight his commitment to addressing significant health challenges. His work continues to pave the way for advancements in the treatment of parasitic infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…